Research Articles
The Double Agents in Our Blood: How Tumor Microvesicles Could Revolutionize Cancer Therapy
Discover how tumor-derived microvesicles, once cancer's messengers, are being transformed into sophisticated delivery systems for cancer therapy.
Aptamers and Oncolytic Viruses: The Dynamic Duo Revolutionizing Cancer Therapy
Discover how aptamers enhance oncolytic viruses' antitumor efficacy in cancer treatment through targeted delivery and immune evasion.
The Survivin Enigma: How a Molecular Target Sparked Hope and Hurdles in Cancer Therapy
Exploring the journey of EZN-3042, a survivin-targeting drug, through clinical trials and its implications for cancer therapy.